Cytokine: X
Volume • Issue
- ISSN: 2590-1532
Cytokine: X is being discontinued as of February 2023. If you are interested in submitting your paper to a journal, please consider:https://www.scienced… Read more
Subscription options
Institutional subscription on ScienceDirect
Request a sales quoteCytokine: X is being discontinued as of February 2023. If you are interested in submitting your paper to a journal, please consider:
https://www.sciencedirect.com/journal/current-research-in-immunologyCurrent Research in Immunology
We would like to express our sincere thanks to the authors, reviewers and editorial board who contributed to the journal over the past years.
Published papers will remain available on ScienceDirect at https://www.sciencedirect.com/journal/cytokine-xCytokine: X.
-------
Cytokine: X is the open access companion journal of https://www.journals.elsevier.com/Cytokine Cytokine and has the same aims and scope and peer-review process.
Cytokine: X offers authors with high-quality research who want to publish in a gold open access journal the opportunity to make their work immediately, permanently, and freely accessible.
Cytokine: X authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright. Please check the APC on the https://www.elsevier.com/journals/cytokine-x/2590-1532/open-access-journaljournal homepage. The journal is indexed in Scopus.
For more information please refer to our https://www.elsevier.com/about/open-science/open-access/faqs-open-access-partner-journalsFAQs for authors
* Devoted exclusively to the study of the molecular biology, genetics, biochemistry, immunology, genome-wide association studies, pathobiology, diagnostic and clinical applications of all known interleukins, hematopoietic factors, growth factors, cytotoxins, interferons, new cytokines, and chemokines, Cytokine provides comprehensive coverage of cytokines and their mechanisms of actions, 12 times a year by publishing original high quality refereed scientific papers from prominent investigators in both the academic and industrial sectors.
We will publish 3 major types of manuscripts:
1) Original manuscripts describing research results.
2) Basic and clinical reviews describing cytokine actions and regulation.
3) Short commentaries/perspectives on recently published aspects of cytokines, pathogenesis and clinical results.
Special issues:
Suggestions for special issue topics and guest editors can be sent to Jenny Henzen, [email protected]
- ISSN: 2590-1532